Position in ELAN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$33,081,118
+$25,682,810 QoQ
Shares Held
1,382,412
+276.3% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
9,349,817 | $126,316,026 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
508,977 | $67,052,628 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
611,747 | $46,401,008 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
75,977 | $45,052,841 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
2,664,306 | $36,900,638 | |
| 6 | ALKS |
Alkermes plc.
|
999,322 | $35,336,024 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
1,382,412 | $33,081,118 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
748,812 | $24,763,212 |
All Filings in ELAN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,081,118 | 1,382,412 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $7,398,308 | 367,344 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $5,073,198 | 355,266 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $5,350,600 | 509,581 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,032,336 | 167,823 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $5,853,950 | 398,499 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $19,987,209 | 1,385,115 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $112,051,023 | 6,882,741 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $23,508,385 | 1,577,744 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $3,409,519 | 303,338 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $31,149,451 | 3,096,367 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $8,817,199 | 938,000 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $10,811,998 | 884,779 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $7,815,768 | 629,796 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $6,527,622 | 332,533 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $1,707,198 | 65,435 | Shares | Other | 2022-05-16 | |
| 2021-03-31 | $3,079,026 | 104,551 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,318,748 | 42,998 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $3,452,999 | 160,979 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||